Cornerstone Capital Management Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | $4.59M | Buy |
115,100
+6,100
| +6% | +$243K | 0.03% | 493 |
|
2017
Q3 | $4.36M | Buy |
109,000
+59,800
| +122% | +$2.39M | 0.03% | 475 |
|
2017
Q2 | $2.12M | Sell |
49,200
-118,600
| -71% | -$5.11M | 0.02% | 710 |
|
2017
Q1 | $5.25M | Sell |
167,800
-8,900
| -5% | -$279K | 0.04% | 448 |
|
2016
Q4 | $4.46M | Sell |
176,700
-1,850
| -1% | -$46.7K | 0.03% | 509 |
|
2016
Q3 | $4.41M | Buy |
178,550
+80,650
| +82% | +$1.99M | 0.03% | 503 |
|
2016
Q2 | $1.99M | Sell |
97,900
-154,700
| -61% | -$3.15M | 0.02% | 727 |
|
2016
Q1 | $3.85M | Buy |
252,600
+129,000
| +104% | +$1.97M | 0.03% | 540 |
|
2015
Q4 | $1.66M | Buy |
123,600
+16,300
| +15% | +$219K | 0.01% | 784 |
|
2015
Q3 | $1.51M | Sell |
107,300
-3,200
| -3% | -$44.9K | 0.01% | 796 |
|
2015
Q2 | $1.88M | Buy |
+110,500
| New | +$1.88M | 0.02% | 734 |
|
2015
Q1 | – | Sell |
-23,800
| Closed | -$198K | – | 1428 |
|
2014
Q4 | $198K | Buy |
+23,800
| New | +$198K | ﹤0.01% | 1092 |
|